Leidos Holdings, Inc.

  • Market Cap: Mid Cap
  • Industry: Aerospace & Defense
  • ISIN: US5253271028
USD
192.42
3.98 (2.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Leidos Holdings, Inc. stock-summary
stock-summary
Leidos Holdings, Inc.
Aerospace & Defense
Leidos Holdings, Inc. is a global science and technology company. The Company provides technology and engineering services and solutions in the defense, intelligence, civil and health markets. Its segments include National Security Solutions (NSS), Information Systems & Global Solutions (IS&GS), Health and Infrastructure (HIS), and Corporate and Other. The NSS segment provides a portfolio of national security solutions and systems. The IS&GS segment focuses on providing information technology, management and engineering services to civil, defense and intelligence agencies of the United States government. HIS segment serves customers, including the United States federal government, state and local governmental agencies, foreign governments, healthcare providers and commercial enterprises. Its infrastructure business is focused on integrating and protecting physical, digital and data domains. The Corporate and Other segment includes the operations of various corporate activities.
Company Coordinates stock-summary
Company Details
1750 PRESIDENTS STREET , RESTON VA : 20190
stock-summary
Tel: 1 571 52660001 571 5266404
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 132 Schemes (40.78%)

Foreign Institutions

Held by 312 Foreign Institutions (12.27%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Roger Krone
Chairman of the Board, Chief Executive Officer
Mr. Robert Shapard
Lead Independent Director
Mr. Gregory Dahlberg
Independent Director
Mr. David Fubini
Independent Director
Dr. Miriam John
Independent Director
Mr. Frank Kendall
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
4,253 Million
(Quarterly Results - Jun 2025)
Net Profit:
393 Million
stock-summary
Industry

Aerospace & Defense

stock-summary
Market cap

USD 22,890 Million (Mid Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.94%

stock-summary
Debt Equity

0.88

stock-summary
Return on Equity

30.43%

stock-summary
Price to Book

4.91